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Abstract
Introduction. Acute peripheral arterial occlusion is a serious medical condition that requires an immediate action. De-
lays in diagnosis or treatment could lead to death or serious disability. The appropriate and early clinical evaluation of 
acute ischaemia is crucial. The goal of therapy for both acute embolic and thrombotic occlusion is reperfusion of the 
ischaemic organ.
Materials and methods. The aim of this study was a retrospective analysis of the demographic and epidemiological data 
of patients admitted to Surgical Department of Mazovian Brodnowski Hospital in Warsaw from 2014 to 2018 due to 
displaying symptoms of acute peripheral arterial ischaemia. 208 patients were evaluated. Our analysis included anthro-
pometric parameters, history of cardiovascular and other important chronic diseases, and addictions. The aetiology, 
localisation, and type of primary surgery were also assessed.
Results. The analysed group contained 112 men (53.8%, average age: 67.9 years) and 96 women (46.2%, average age: 
76.4). We find a statistically significant correlation was found between epidemiological factors [i.e. age, hypertension, 
atrial fibrillation (AF), peripheral artery disease, myocardial infarction, and smoking] and gender. Embolic ischaemia 
occurred in 50.5% of cases. Thrombosis was diagnosed in the remaining 49.5%. Lower extremity ischaemia occurred 
most frequently (81.3%). Open embolectomy/thrombectomy was the primary surgery in 155 cases. We find significance 
of the aetiology in relation to the type of intervention and to the ischaemia localisation, but there was no significance in 
terms of mortality. The presence of ischaemic heart disease, atherosclerosis and tobacco smoking were relevant factors 
affecting the aetiology of acute ischaemia.
Conclusion. Acute arterial ischaemia can occur regardless of gender. Embolic and thrombotic aetiologies occur with 
a very similar frequencies. Upper extremity arterial thrombosis occurs very rarely. An embolism is more often respon-
sible for acute intestinal ischaemia. In patients with atherosclerosis and a history of previous vascular surgery, the 
presence of a vascular graft/stent graft is associated with a higher risk of arterial thrombosis. Among patients with AF 
and who were receiving vitamin K antagonists, the average level of international normalized ratio was non-therapeutic. 
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Introduction
Acute peripheral arterial occlusion is a serious medical condi-
tion that requires an immediate reaction. A delay in diagnosis 
or treatment can lead to death or serious disability. The ap-
propriate and early clinical evaluation of acute ischaemia is 
crucial to identify the aetiology of the ischaemic organ. Acute 
arterial ischaemia can be caused by various factors (Table 1) 
[1]. The clinical manifestation of acute arterial occlusion 
depends on the affected organ. A painless acute onset of 
a neurologic deficit suggests brain ischaemia. Pain, loss of 
sensation, and later loss of motor function with coexisting low 
body temperature, pale extremities and pulselessness may 
be symptoms of upper/lower limb acute ischaemia. Bowel 
ischaemia manifests as abdominal pain, nausea, vomiting, 
intestinal paralysis and sometimes diarrhoea [2].
Despite having the same effect as that of acute ischae-
mia, the clinical presentation of acute embolism versus 
thrombosis may be different (Table 2) [3]. Most arterial 
emboli originate from the heart. Atrial fibrillation (AF) is 
the most common cause of embolism. The most frequent 
manifestations of cardiac embolic events are strokes and 
peripheral ischaemic events. Clots formed in the left side of 
the heart are responsible for 55–87% of peripheral arteries 
emboli including visceral vessels [4].
The goal of therapy for both acute embolic and throm-
botic occlusion is reperfusion of the ischaemic organ. Intra-
venous heparin administration is the first step in treatment. 
This prevents propagation of the thrombus both proximally 
and distally, while maintaining the patency of collateral 
vessels. Therefore, it will help to reduce the extent of the 
ischaemic injury. The restoration of arterial blood flow 
requires open surgery or endovascular intervention (throm-
bolysis or thrombectomy). The type of treatment depends 
on the degree of limb ischaemia, the occlusion localisation, 
the cause of the occlusion (embolic vs. thrombotic), and 
the general condition of the patient [5].
The aim of this study was a retrospective analysis of the 
demographic and epidemiological data of patients admitted 
to the Department of General and Vascular Surgery from 
January 2014 to November 2018 due to symptoms of acute 
peripheral arterial ischaemia.
Table 1. Acute arterial ischaemia
Embolic Thrombotic
Atherosclerotic heart disease (CAD, MI, arrhythmia) Atherosclerosis
Valvular heart disease (rheumatic, degenerative,  
congenital, bacterial, prosthetic)
Low flow states (CHF, hypovolemia, hypotension)
Artery-to-artery (aneurysm, atherosclerotic disease) Genetic states of hypercoagulation
Idiopathic Vascular grafts (progression of disease, intimal hyperplasia)
Paradoxical embolus Arterial plaque rupture
Trauma Aortic/arterial dissection
Iatrogenic External compression
Other (air, amniotic fluid, fat, tumour, drugs, chemicals) Trauma
Iatrogenic
CAD — coronary artery disease; MI —myocardial infarction; CHF — congestive heart failure
Table 2. Differences in clinical presentation of acute arterial ischaemia (embolism vs. thrombosis)
Clinical presentation Embolism Thrombosis
Cardiac dysrhythmia Yes No
Onset Sudden Sudden or slower
Severity of signs and symptoms Severe Less severe
History of claudication or rest pain No Yes
Risk factors for peripheral vascular disease* No Yes
Contralateral pulse exam (limb ischaemia) Normal Abnormal
Exam findings of chronic limb ischaemia** No Yes
*Risk factors include cardiac disease, prior myocardial infarction, hyperlipidaemia, stroke, family history of peripheral vascular disease, smoking, and diabetes mellitus; **diminished hair growth, thin skin, 
thick nails, and arterial ulcerations
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Materials and methods
Between January 2014 and November 2018, 212 patients 
were admitted to our Department with a diagnosis of acute 
arterial ischaemia. An eventual total of 208 patients were 
evaluated. Four patients were excluded due to the lack 
of full data. Analysis included basic anthropometrical pa-
rameters, a history of cardiovascular and other important 
chronic diseases, and addictions. The aetiology (embolic 
or thrombotic), the localisation (lower limb, upper limb, 
viscera), and the type of primary surgery was also assessed. 
Laboratory tests at admission were included. Mortality 
during hospitalisation and within three to 12 months 
after discharge was also considered. Patients with acute 
myocardial infarction, arterial injury or ischaemic stroke 
were excluded from evaluation. Basic statistical analysis 
regarding variables was made (t-Student, χ², p value)
Results
The analysed group contained 112 men (53.8%) aged from 
31 to 101 years (average 67.9) and 96 women (46.2%) aged 
from 41 to 95 (average 76.4). The incidence of ischaemic 
heart disease was similar in the male and female groups, 
but its complications were significantly more common in 
men. Myocardial infarction (MI) occurred in 8.3% of the 
women, but in 25% of the men, despite the fact that males 
are more often treated invasively [percutaneous coronary 
intervention (PCI), coronary artery bypass grafting (CABG)]. 
The appearance of peripheral artery disease (PAD) was 
more frequently observed in the group of men. Atrial fibril-
lation was diagnosed twice as often as in women. In the 
female group stroke, hypothyroidism, peptic ulceration and 
arthritis were more frequently reported (Table 3). A sta-
tistically significant correlation between epidemiological 
factors (age, hypertension, AF, PAD, MI, PCI, smoking) and 
gender was found.
Embolic ischaemia occurred in 105 (50.5%) patients. 
Thrombosis was diagnosed in 103 (49.5%) cases. Lower ex-
tremity ischaemia occurred most frequently (81.3%). There 
were 30 cases of upper extremity ischaemia (14.4%), nearly 
all as a result of emboli (29 patients). Acute mesenteric 
ischaemia (AMI) was observed in nine patients (4.3%); in 
six of these cases superior mesenteric artery/celiac trunk 
embolism and in the remaining three cases thrombosis 
due to visceral vessel atherosclerosis.
Open embolectomy/thrombectomy was the primary 
surgery in 155 cases (74.5%). 54 such procedures (25.7%) 
were performed due to thrombosis. Endovascular mechan-
ical thrombectomy was performed in 25 cases (12.0%) on 
22 patients. Direct catheter thrombolysis (DCT) was the 
first choice for 26 patients (12.5%). Primary amputation 
was performed in two patients with thrombosis (1.0%) 
(Figure 1). Among patients with PAD and a history of previ-
ous vascular surgeries, occlusion caused by graft thrombo-
sis occurred in 26 cases (12.5%). Of these, 16 concerned 
previous femoro-popliteal, one case ilio-femoral, one case 
femoro-femoral, and eight cases aorto-bifemoral bypass. 
Only one (0.5%) patient with a history of PAD (ilio-femoral 
bypass) and atrial fibrillation was admitted with acute limb 
ischaemia caused by graft embolic occlusion. Thrombosis 
after previous endovascular treatment occurred in five 
patients (2.4%) — in three after peripheral stent grafts 
— one after aortic stent graft — and one after bare stent 
graft. Popliteal artery aneurysm was the cause of acute 
limb ischaemia in three cases (1.4%); of these, one case 
was a primary aneurysm thrombosis, and two cases were 
of secondary stent graft thrombosis. There was statistical 
significance of the aetiology in correlation with the type of 
primary intervention and the ischaemia localisation.
There was no significance in the in-hospital and 
post-hospitalisation mortality. Overall in-hospital morta-
lity was 13% (27 patients) — 15 deaths in consequence 
of embolism, and 12 deaths in the course of thrombosis. 
Post hospitalisation mortality, within three to 12 months 
of follow up, was 39 (18.8%). Seven patients died due to 
a stroke, and seven due to myocardial infarction. Peripheral 
arterial disease and its complications were responsible 
for seven deaths (3.4%). Cancer was the cause of death 
of four patients (1.9%). In the other 14 cases (6.7%) of 
post-hospitalisation death, the cause was different or un-
known. Overall mortality in the study group was 66 (31.7%). 
Table 4 shows the detailed characteristics concerning the 
aetiology and localisation of ischaemia.
The comparative cardiovascular factors regarding 
thrombotic or embolic cause of ischaemia are summarised 
in Table 5. The presence of ischaemic heart disease (IHD), 
PAD and tobacco smoking were relevant factors according 
the aetiology of acute ischaemia.
Thrombotic peripheral arterial ischaemia occurred in 
100 of 123 patients with a history of PAD (81.3%). Among 
85 patients without a history of PAD, arterial thrombosis 
was observed in three cases (3.5%; one case PAA throm-
bosis, two cases of idiopathic thrombosis).
Laboratory tests analysis was divided into groups of 
either thrombotic (T) or embolic (E) aetiology. Mean hae-
moglobin level was similar in both groups (12.6 g/dL vs. 
12.3 g/dL). Mean platelet level in the thrombotic group 
was 271.8 × 103/mL vs. 236.4 × 103/mL in the embolic 
group. Average serum creatinine level was 2.3 mg/dL (T) 
vs. 1.2 mg/dL (E). International normalized ratio (INR) vas 
similar in both groups: 1.26 (T) vs. 1.31 (B).
15 patients with a history of AF were treated by vitamin 
K antagonists (VKA). In this group, INR was below the the-
rapeutic level (mean 1.7). Anticoagulants taken before ho-
spitalisation were divided into two groups in relation to the 
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Table 3. Comorbidities in correlation with gender
Parameter Female Male p value
Number of pts. (years) 96 (46.2%) 112 (53.8%) – –
Age (average) 41–95 (76.4, SD: 10.9) 31–101 (67.9, SD: 11.1) t(206) = 5.57 p < 0.005
BMI (average) 27.1 (SD: 5.37) 25.7 (SD: 4.05) t(89) = 1.28 p > 0.05
Coronary disease: 41 (42.7%) 44 (39.3%) χ²(1) = 0.3 p > 0.05
• myocardial infarction 8 (8.3%) 28 (25.0%) χ²(1) = 10.2 p < 0.01
• percutaneous coronary intervention 5 (5.2%) 15 (13.4%) χ²(1) = 4.0 p < 0.05
• coronary artery bypass grafting 1 (1.04%) 6 (5.36%) χ²(1) = 2.9 p > 0.05
Chronic obstructive pulmonary disease 3 (3.1%) 7 (6.3%) χ²(1) = 1.1 p > 0.05
Peripheral artery disease (PAD) 40 (41.7%) 83 (74.1%) χ²(1) = 22.5 p < 0.0005
Carotid stenosis 2 (2.1%) 5 (4.5%) χ²(1) = 0.9 p > 0.05
Hyperlipidaemia 19 (19.8%) 23 (20.5%) χ²(1) = 0.1 p > 0.05
Hypertension 70 (72.9%) 78 (69.6%) χ²(1) = 4.2 p < 0.05
Diabetes 30 (31.3%) 22 (19.6%) χ²(1) = 3.7 p > 0.05
Atrial fibrillation (AF): 43 (44.8%) 25 (22.3%) χ²(1) = 11.9 p < 0.001
• paroxysmal AF 11 (25.6%) 5 (20.0%) χ²(1) = 2.6 p > 0.05
Ventricular arrhythmia 1 (1.0%) 3 (2.7%) – –
Neurological symptoms:
• transient ischaemic attack (TIA) 0 (0.0%) 3 (2.7 %) – –
• stroke:
 — ischaemic 19 (19.8%) 13 (11.6%) χ²(1) = 2.7 p > 0.05
 — haemorrhagic 5 (5.2%) 3 (2.7%) χ²(1) = 0.9 p > 0.05
Chronic kidney disease 8 (8.3%) 9 (8.0%) χ²(1) = 0.0 p > 0.05








Active cancer 5 (5.2%) 4 (3.6%) – –
Hypothyroidism 1 (1.0%) 1 (0.9%) – –
Hyperthyroidism 4 (4.2%) 2 (1.8%) χ²(1) = 1.1 p > 0.05
Peptic ulcer 8 (8.33%) 2 (1.8%) χ²(1) = 2.9 p > 0.05
GI tract bleeding 1 (1.0%) 2 (1.8%) – –
Arthritis 6 (6.1%) 3 (2.7%) χ²(1) = 0.1 p > 0.05
Alcohol abuse 2 (2.1%) 11 (9.8%) – –
Smoking: 25 (26.0%) 45 (40.2%) χ²(1) = 11.2 p < 0.001
• pack-years (average) 29.7 38.1 – –
presence of AF or PAD (Table 6, Figure 2A, B). Coexistence 
of both diseases was found in 34 patients (16.4%). Sta-
tistical analysis showed a significant correlation between 
the occurrence of AF/PAD and anticoagulants/antiplatelet 
drugs administration before hospitalisation.
Discussion
Acute arterial ischaemia caused by an embolism secondary 
to valvular heart disease was the most common cause. 
Thrombosis occurred on the base of severe, vulnerable 
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Table 4. Aetiology, localisation and detailed characteristics of ischaemia
Parameter Embolism Thrombosis
Total 105 (50.5%) 103 (49.5%)
Lower extremity 169 (81.3%)
70 (33.7%) 99 (47.6%)
Upper extremity 30 (14.4%)
29 (13.9%) 1 (0.5%)
Acute mesenteric ischaemia 9 (4.3%)
6 (2.9%) 3 (1.4%)
Type of primary intervention
Open surgery 155 (74.5%)
101 (48.6%) 54 (26.0%)
Endovascular thrombectomy 25 (12.0%)
3 (1.4%) 22 (10.6%)
Direct catheter thrombolysis (DCT) 26 (12.5%)
1 (0.5%) 25 (12.0%)
Primary amputation 0 (0.00%) 2 (1.0%)
Vascular graft occlusion 1 (0.5%) 26 (12.5%)
Stent occlusion 0 (0.00%) 5 (2.4%)
Popliteal artery aneurysm (PAA) – 3 (1.4%)
In-hospital mortality Overall: 27 (13.0%)
15 (7.2%) 12 (5.8%)
Post-hospitalisation mortality Overall: 39 (18.8%)
25 (12.0%) 14 (6.7%)
χ² p value
Type of primary intervention 54.031 0.000
Previous vascular surgeries – –
Location 32.820 0.000
In-hospital mortality 0.383 0.536
Post-hospitalisation mortality 3.819 0.051
 
Figure 1. Type of primary intervention depending on the aetiology
atherosclerotic lesions [6]. Theories concerning the aetio-
logy of acute ischaemia have changed over recent years. 
More recent studies have confirmed the increasing rate of 
a thrombotic cause of acute ischaemia [7].
In our presented study, the number of patients was 
comparable in both groups. In the material presented by 
Hemingway et al., acute limb ischaemia caused by arterial 
thrombosis was observed four times more often compared 
to an embolism [8], and a similar result was demonstrated 
by Genovese et al. [9]. After excluding thrombosis related 
to previous surgery, the primary cause of ALI was similar 
to our material. Serum creatinine level was higher in the 
thrombotic group and it has been proved that impaired 
renal function is a risk factor for PAD and thrombotic com-
plications [10]. Some studies have shown that patients 
with acute limb ischaemia have a slightly higher rate of 
cerebrovascular disease (CVD) [11]. Our study showed no 
difference between the thrombotic and embolic groups in 
terms of CVD rate. The thrombosis group represents an 
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extremely high percentage of PAD (97.1%). Active smoking 
was observed more often (38.8%) in the thrombotic group. 
Smoking is also an obvious risk factor for atherosclerosis 
and renal failure [12].
In the analysed group of patients treated due to arterial 
embolism while receiving VKA, the INR level was non-the-
rapeutic (mean 1.7) [13]. In the groups of patients with 
AF and PAD history, there was a very high rate of patients 
without any antithrombotic treatment before hospitalisation 
(AF 54.4%. PAD 43.1%).
Acute upper limb ischaemia occurs less frequently than 
the lower limb variation. The most common cause of arm 
ischaemia is a cardiac embolism. Atherosclerosis, except 
of the subclavian arteries, is rare in upper limb arteries. 
Thoracic outlet syndrome and proximal subclavian artery 
aneurysm are other rare causes of embolisation. Arm 
ischaemia threatens the limb to a lesser extent, and the 
treatment decision is thus less urgent. The main reason 
Table 5. Comparison of cardiovascular factors regarding the aetiology of acute ischaemia
Parameter Total Embolism Thrombosis p value
Average BMI 26.3 26.6 26.1 t(89) = 0.71 p > 0.05
PAD 123 (59.1%) 23 (21.9%) 100 (97.1%) χ²(1) = 124.2 p < 0.0005
Diabetes 52 (25.0%) 30 (28.6%) 22 (21.4%) χ²(1) = 1.6 p > 0.05
Smoking 63 (30.3%) 23 (21.9%) 40 (38.8%) χ²(1) = 10.0 p < 0.01
IHD 85 (40.9%) 51 (48.6%) 34 (33.0%) χ²(1) = 5.5 p < 0.05
MI 36 (17.2%) 15 (14.3%) 21 (20.4%) χ²(1) = 2.2 p > 0.05
CVD 43 (20.7%) 20 (19.1%) 23 (22.3%) χ²(1) = 0.8 p > 0.05
Carotid stenosis 7 (3.4%) 4 (3.8%) 3 (2.9%) χ²(1) = 0.2 p > 0.05
BMI — body mass index; PAD — peripheral artery disease; IHD — ischaemic heart disease; MI — myocardial infarction; CVD — cerebrovascular disease (transient ischaemic attack/stroke)

















VKA 16 (23.5%) 8 (6.5%)
Anti-IIa 4 (5.9%) 3 (2.4%))
Anti-Xa 6 (8.8%) 6 (4.9%)
LMWH 3 (4.4%) 2 (1.6%)
ASA 6 (8.8%) 23 (18.7%)
SAPT 2 (2.9%) 13 (10.6%)
DAPT 1 (1.5%) 15 (12.2%)




AF — atrial fibrillation; PAD — peripheral artery disease; VKA — vitamin K antagonists; Anti-IIa — 
direct thrombin inhibitor; Anti-Xa — factor Xa inhibitor; LMWH — low molecular weight heparin;  
ASA — acetylsalicylic acid only; SAPT — single antiplatelet therapy (clopidogrel or cilostazol);  
DAPT — dual antiplatelet therapy
Figure 2A, B. Anticoagulants and antiplatelet drugs administration in correlation to presence of peripheral artery disease (PAD)/atrial fibril-
lation (AF); DAPT — dual antiplatelet therapy; SAPT — single antiplatelet therapy; ASA — acetylsalicylic acid; LMWH — low molecular weight 
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is to prevent late complications such as arm fatigue and 
chronic pain [14–16].
Acute mesenteric ischaemia (AMI) is uncommon. 
Women are affected three times more often than men 
[17]. Arterial embolism is the most common pathophysio-
logy of AMI [18]. In contrast, data from our study shows 
that AMI occurred 3.5 times more often in the male group 
(seven males vs. two females) despite a significantly 
lower AF rate.
Popliteal artery aneurysm is relatively uncommon, with 
an estimated incidence rate of 0.1–2.8% and has been 
shown to be a rare cause of thromboembolism [19].
Our study presents the comprehensive characteristics 
of patients with acute arterial ischaemia. However, in order 
to draw clinical conclusions, a multi-centre analysis and 
a larger group of patients would be required.
Conclusions
Acute arterial ischaemia occurs regardless of gender. In 
our material, ischaemia caused by embolus and thrombus 
occurred with similar frequencies. Upper extremity arterial 
thrombosis occurs very rarely. An embolism is more often 
responsible for acute intestinal ischaemia. In patients 
with a history of PAD and a history of previous vascular 
interventions, the presence of a vascular graft/stent graft is 
associated with a higher risk of arterial thrombosis. Among 
patients with AF and receiving VKA, the average of level of 
INR is non-therapeutic.
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Streszczenie
Wstęp. Ostra niedrożność tętnicy obwodowej może prowadzić do niedokrwienia zaopatrywanego przez nią narządu 
wymagającego pilnej reakcji. Opóźnienie w rozpoznaniu i leczeniu może doprowadzić do śmierci lub inwalidztwa.
Materiał i metody. Celem pracy była retrospektywna analiza danych demograficznych i epidemiologicznych pacjentów 
z objawami ostrego niedokrwienia przyjętych do kliniki autorów w latach 2014–2018. Badana grupa obejmowała 
112 mężczyzn (53,8%; średni wiek 67,9 roku) i 96 kobiet (46,2%; średni wiek 76,4 roku). Ocena uwzględniała dane 
antropometryczne, wywiad chorób układu sercowo-naczyniowego, innych chorób przewlekłych i uzależnień. Analizowano 
przyczynę i lokalizację niedokrwienia oraz rodzaj interwencji chirurgicznej.
Wyniki. Zauważono istotny związek między płcią a wiekiem, nadciśnieniem tętniczym, migotaniem przedsionków, 
miażdżycą obwodową, zawałem serca, paleniem tytoniu. Niedokrwienie na podłożu zatorowym wystąpiło w 50,5% przy-
padków, a zakrzepica tętnicza — w 49,5%. Niedokrwienie kończyny dolnej występowało najczęściej (81,3%). Otwarta 
embolektomia/trombektomia była pierwotną operacją w 155 przypadkach. Stwierdzono istotny związek między etiologią 
niedokrwienia a chorobą niedokrwienną serca, niedokrwieniem kończyn dolnych, paleniem tytoniu, rodzajem interwencji 
i lokalizacją zmian. Nie stwierdzono istotnej różnicy w śmiertelności.
Wnioski. Ostre niedokrwienie tętnicze może wystąpić niezależnie od płci. Ostre niedokrwienie kończyny górnej w na-
stępstwie zakrzepu tętniczego występuje bardzo rzadko. Zator jest częściej odpowiedzialny za ostre niedokrwienie jelit. 
Pacjentów z miażdżycą tętnic obwodowych i po przebytych operacjach naczyniowych cechuje zwiększone ryzyko zakrze-
picy tętniczej. Wśród pacjentów z wywiadem migotania przedsionków przyjmujących antagonistów witaminy K wartość 
międzynarodowego współczynnika znormalizowanego jest często nieterapeutyczna.
Słowa kluczowe: miażdżyca, ostre niedokrwienie, zator, zakrzep, choroba tętnic obwodowych, migotanie przedsionków
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